NEWTOWN, Pa., Sept. 5, 2024 /PRNewswire/ -- Edelson Lechtzin LLP, a leading class action law firm, announces that investors of Sage Therapeutics, Inc. common stock (NASDAQ: SAGE) between April 12, 2021, and July 23, 2024, inclusive (the "Class Period") may seek appointment as lead plaintiff in the pending securities fraud class action lawsuit. A copy of the Complaint can be found HERE. Investors who purchased Sage stock may move the U.S. District Court for the Southern District of New York to appoint them a ...